相似文献
1
The economic value of a quadrivalent versus trivalent influenza vaccine.
Vaccine. 2012 Dec 14;30(52):7443-6. doi: 10.1016/j.vaccine.2012.10.025. Epub 2012 Oct 19.
2
Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Hum Vaccin Immunother. 2017 Jan 2;13(1):81-89. doi: 10.1080/21645515.2016.1225636. Epub 2016 Sep 13.
3
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
Hum Vaccin Immunother. 2016 Sep;12(9):2259-68. doi: 10.1080/21645515.2016.1180490. Epub 2016 May 11.
4
Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
Hum Vaccin Immunother. 2015;11(3):564-71. doi: 10.1080/21645515.2015.1011016.
5
Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain.
Hum Vaccin Immunother. 2016 Sep;12(9):2269-77. doi: 10.1080/21645515.2016.1182275. Epub 2016 May 16.
6
Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
BMC Infect Dis. 2015 Oct 27;15:465. doi: 10.1186/s12879-015-1193-4.
7
From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain.
PLoS One. 2020 May 21;15(5):e0233526. doi: 10.1371/journal.pone.0233526. eCollection 2020.
8
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.
Hum Vaccin Immunother. 2018;14(8):1867-1873. doi: 10.1080/21645515.2018.1469368. Epub 2018 Jun 18.
9
Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
Value Health. 2016 Dec;19(8):964-975. doi: 10.1016/j.jval.2016.05.012. Epub 2016 Jul 15.
10
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.
BMC Infect Dis. 2014 Nov 25;14:618. doi: 10.1186/s12879-014-0618-9.
引用本文的文献
1
Fighting the flu in the tropics: The role of influenza vaccination in Southeast Asia.
Asia Pac Allergy. 2025 Sep;15(3):212-220. doi: 10.5415/apallergy.0000000000000195. Epub 2025 Mar 17.
2
Streptococcus pneumoniae and influenza vaccination rates in oncological patients - data from Germany.
Support Care Cancer. 2024 Nov 21;32(12):813. doi: 10.1007/s00520-024-09023-y.
3
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra 2.0].
J Prev Med Hyg. 2023 Mar 2;63(4 Suppl 1):E1-E140. doi: 10.15167/2421-4248/jpmh2022.63.4s1. eCollection 2022 Dec.
4
Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review.
Value Health. 2023 May;26(5):768-779. doi: 10.1016/j.jval.2022.11.008. Epub 2022 Nov 25.
5
Influenza Vaccination Assessment according to a Value-Based Health Care Approach.
Vaccines (Basel). 2022 Oct 8;10(10):1675. doi: 10.3390/vaccines10101675.
6
The Value(s) of Vaccination: Building the Scientific Evidence According to a Value-Based Healthcare Approach.
Front Public Health. 2022 Mar 9;10:786662. doi: 10.3389/fpubh.2022.786662. eCollection 2022.
7
Animal Models Utilized for the Development of Influenza Virus Vaccines.
Vaccines (Basel). 2021 Jul 14;9(7):787. doi: 10.3390/vaccines9070787.
8
Influenza vaccination: protecting the most vulnerable.
Eur Respir Rev. 2021 Jan 13;30(159). doi: 10.1183/16000617.0258-2020. Print 2021 Mar 31.
9
Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency.
Front Immunol. 2020 Aug 19;11:1876. doi: 10.3389/fimmu.2020.01876. eCollection 2020.
10
Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine.
Hum Vaccin Immunother. 2020 Aug 2;16(8):1746-1752. doi: 10.1080/21645515.2019.1701912. Epub 2020 Apr 7.
本文引用的文献
1
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
Vaccine. 2012 Mar 2;30(11):1993-8. doi: 10.1016/j.vaccine.2011.12.098. Epub 2012 Jan 5.
2
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.
MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1128-32.
3
Pricing of new vaccines.
Hum Vaccin. 2010 Aug;6(8):619-26. doi: 10.4161/hv.6.8.11563.
4
The need for quadrivalent vaccine against seasonal influenza.
Vaccine. 2010 Sep 7;28 Suppl 4:D45-53. doi: 10.1016/j.vaccine.2010.08.028.
5
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Vaccine. 2010 Feb 25;28(9):2149-56. doi: 10.1016/j.vaccine.2009.11.068. Epub 2009 Dec 8.
6
The impact of influenza on working days lost: a review of the literature.
Pharmacoeconomics. 2008;26(11):911-24. doi: 10.2165/00019053-200826110-00004.
7
Digital decision making: computer models and antibiotic prescribing in the twenty-first century.
Clin Infect Dis. 2008 Apr 15;46(8):1139-41. doi: 10.1086/529441.
8
The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Vaccine. 2007 Jun 28;25(27):5086-96. doi: 10.1016/j.vaccine.2007.03.046. Epub 2007 Apr 20.
9
School absenteeism, parental work loss, and acceptance of childhood influenza vaccination.
Am J Med Sci. 2001 Mar;321(3):178-80. doi: 10.1097/00000441-200103000-00004.
Zotero 插件